ClinicalTrials.gov
ClinicalTrials.gov Menu

Consent for Obtaining Additional Bone Marrow Specimens at Time of Diagnostic Bone Marrow Procedure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01048060
Recruitment Status : Recruiting
First Posted : January 13, 2010
Last Update Posted : November 9, 2016
Sponsor:
Information provided by (Responsible Party):
Stanford University

Brief Summary:
The purpose of this study is to collect bone marrow samples for experimental studies.

Condition or disease Intervention/treatment
Brain Cancer Cancer Procedure: Bone marrow specimen banking

Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Consent for Obtaining Additional Bone Marrow Specimens at the Time of a Diagnostic Bone Marrow Procedure
Study Start Date : February 2002
Estimated Primary Completion Date : February 2060
Estimated Study Completion Date : February 2060



Primary Outcome Measures :
  1. Cancer Research in Future [ Time Frame: 1 time ]
    No new information will be gained form this study. However, the specimens obtained me be used for other studies to progress cancer research in the future.


Biospecimen Retention:   Samples With DNA
bone marow


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 21 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Subjects who are having a bone marrow procedure done as part of their standard oncology work-up will be eligible to be consent on this study.
Criteria

Inclusion Criteria:

  • Subjects who are having a bone marrow procedure done as part of their standard oncology work-up will be eligible to be consent on this study.

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01048060


Contacts
Contact: Christina Baggott baggott@stanford.edu

Locations
United States, California
Stanford University School of Medicine Recruiting
Stanford, California, United States, 94305
Contact: Christina Baggott       baggott@stanford.edu   
Contact: Cancer Clinical Trials Office    (650) 498-7061      
Principal Investigator: Neyssa Marina         
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Dr. Neyssa Marina Stanford University

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT01048060     History of Changes
Other Study ID Numbers: BANKPEDSBMS0001
78014
SU-11022007-789 ( Other Identifier: Stanford University )
First Posted: January 13, 2010    Key Record Dates
Last Update Posted: November 9, 2016
Last Verified: November 2016

Additional relevant MeSH terms:
Brain Neoplasms
Central Nervous System Neoplasms
Nervous System Neoplasms
Neoplasms by Site
Neoplasms
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases